Evidence map›Paper›PMID 21931216›Full record

ArticleActa crystallographica. Section D, Biological crystallography2011

Structural studies of human glioma pathogenesis-related protein 1.

Oluwatoyin A Asojo, Raymond A Koski, Nathalie Bonafé

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Biological crystallography, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. CAP superfamily proteins in human: a new target for cancer therapy.Medical oncology (Northwood, London, England) · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Frontiers in chemistry · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The structure of hookworm platelet inhibitor (HPI), a CAP superfamily member from Ancylostoma caninum.Acta crystallographica. Section F, Structural biology communications · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Oluwatoyin A AsojoDepartment of Pathology and Microbiology, College of Medicine, Nebraska Medical Center, Omaha, NE 68198-6495, USA. oasojo@unmc.edu
Raymond A Koski
Nathalie Bonafé
Nebraska Medical Center · US

Funding

Structural Basis of Multidrug resistance in CancerK01CA113486 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ASOJO, OLUWATOYIN AJIBOLA · 2005 to 2009
$781k
Glioma Therapeutics Targeting Glioma Pathogenesis-related ProteinR43CA123991 · NCI · L2 DIAGNOSTICS, LLC · PI BONAFE, NATHALIE MARIE · 2008 to 2008
$219k
NCI NIH HHS K01 CA113486NCI NIH HHS K01CA113486NCI NIH HHS R43 CA123991NCI NIH HHS R43CA123991
6 · The paper itself

Abstract

Human glioma pathogenesis-related protein 1 (GLIPR1) is a membrane protein that is highly upregulated in brain cancers but is barely detectable in normal brain tissue. GLIPR1 is composed of a signal peptide that directs its secretion, a conserved cysteine-rich CAP (cysteine-rich secretory proteins, antigen 5 and pathogenesis-related 1 proteins) domain and a transmembrane domain. GLIPR1 is currently being investigated as a candidate for prostate cancer gene therapy and for glioblastoma targeted therapy. Crystal structures of a truncated soluble domain of the human GLIPR1 protein (sGLIPR1) solved by molecular replacement using a truncated polyalanine search model of the CAP domain of stecrisp, a snake-venom cysteine-rich secretory protein (CRISP), are presented. The correct molecular-replacement solution could only be obtained by removing all loops from the search model. The native structure was refined to 1.85 Å resolution and that of a Zn2+ complex was refined to 2.2 Å resolution. The latter structure revealed that the putative binding cavity coordinates Zn2+ similarly to snake-venom CRISPs, which are involved in Zn2+-dependent mechanisms of inflammatory modulation. Both sGLIPR1 structures have extensive flexible loop/turn regions and unique charge distributions that were not observed in any of the previously reported CAP protein structures. A model is also proposed for the structure of full-length membrane-bound GLIPR1.

Indexed as

Amino Acid SequenceBinding SitesConserved SequenceCrystallography, X-RayHumansMembrane ProteinsModels, MolecularMolecular Sequence DataNeoplasm ProteinsNerve Tissue ProteinsProtein ConformationProtein Structure, TertiaryRecombinant ProteinsSnake VenomsStructural Homology, ProteinZincGLIPR1 protein, humanMembrane ProteinsNeoplasm ProteinsNerve Tissue ProteinsRecombinant ProteinsSnake VenomsZinc

Identifiers

PMID21931216
PMCPMC3176621
OpenAlexW2081679686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.